#cervical cancer

The COVID-19 pandemic has interrupted key health services for children and adolescents, including HPV vaccination for cancer prevention.

However, other malignancies caused by human papillomavirus, including anal and oral cancers, are on the rise.

Studies have shown an alarming drop in screenings—and more advanced cancer—during the COVID-19 pandemic.

New study reveals that more work is needed to enhance adherence to recommended cancer screening in Canada.

The decrease is largely due to improved lung cancer treatment, but the impact of COVID-19 is not yet known.

A checkpoint inhibitor combination and an antibody-drug conjugate may offer new treatment options.

Compared with unvaccinated women, the risk among women vaccinated before age 17 dropped by almost 90%.

New guidelines assert that cervical cancer is best detected by a human papillomavirus test, but some groups disagree.

The American Cancer Society now calls for vaccination of girls and boys starting at age 9.

Women with gynecologic cancer who watched these classic films during cancer treatment saw an improvement in their emotional well-being.

Screening appointments for cervix, colon and breast cancer are down between 86% and 94%.

Cancer Health spoke with the Foundation for Women’s Cancer about gynecologic cancer education, prevention and eradication.

More widespread vaccination could reduce cervical, anal, oral and other cancers caused by human papillomavirus.

This finding from a large study surprised and concerned researchers.

Individuals with any mental health disorder are 25% less likely to get screened.